Bod, Lloyd
Kye, Yoon-Chul http://orcid.org/0000-0003-0261-5247
Shi, Jingwen
Torlai Triglia, Elena http://orcid.org/0000-0002-6059-0116
Schnell, Alexandra http://orcid.org/0000-0003-3442-7750
Fessler, Johannes
Ostrowski, Stephen M.
Von-Franque, Max Y. http://orcid.org/0000-0002-5232-6454
Kuchroo, Juhi R.
Barilla, Rocky M. http://orcid.org/0000-0002-8062-7246
Zaghouani, Sarah http://orcid.org/0000-0002-4467-6542
Christian, Elena
Delorey, Toni Marie http://orcid.org/0000-0001-6614-3803
Mohib, Kanishka http://orcid.org/0000-0002-7332-5530
Xiao, Sheng
Slingerland, Nadine http://orcid.org/0000-0002-3134-6472
Giuliano, Christopher J. http://orcid.org/0000-0002-0586-6095
Ashenberg, Orr
Li, Zhaorong http://orcid.org/0000-0002-5268-6986
Rothstein, David M. http://orcid.org/0000-0002-9455-7971
Fisher, David E.
Rozenblatt-Rosen, Orit http://orcid.org/0000-0001-6313-3570
Sharpe, Arlene H. http://orcid.org/0000-0002-9736-2109
Quintana, Francisco J. http://orcid.org/0000-0001-8156-0736
Apetoh, Lionel http://orcid.org/0000-0002-2774-438X
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Kuchroo, Vijay K. http://orcid.org/0000-0001-7177-2110
Article History
Received: 2 November 2021
Accepted: 17 May 2023
First Online: 21 June 2023
Competing interests
: V.K.K. has an ownership interest in and is a member of the scientific advisory board for Tizona Therapeutics, Bicara Therapeutics, Compass Therapeutics, Larkspur Biosciences and Trishula Therapeutics. L.B., S.X. and V.K.K. are named as inventors on a provisional patent that has been filed including work from this study. L.A. performed consultancy work for Roche, Merck, Bristol-Myers Squibb and Orega Biotech, and was a recipient of a research grant from Sanofi. A.R. and V.K.K. are co-founders of and have an ownership interest in Celsius Therapeutics. A.R. is also a co-founder and equity holder in Immunitas Therapeutics and was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Asimov and Neogene Therapeutics until 31 July 2020. A.R. and O.R.-R. are listed as co-inventors on patent applications filed by the Broad Institute to inventions relating to single-cell genomics. The interests of V.K.K. were reviewed and managed by the Brigham and Women’s Hospital and Partners Healthcare in accordance with their conflict-of-interest policies. The interests of A.R. were reviewed and managed by the Broad Institute and HHMI in accordance with their conflict-of-interest policies. Since 1 August 2020, A.R. has been an employee of Genentech, a member of the Roche group. O.R.-R. is currently an employee of Genentech. The other authors declare no competing interests.